• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about EXEL

Recent news which mentions EXEL

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Recap of Tuesday's Biotech Catalysts - End of the Day Summary
June 21, 2022
Tickers ABBV ACER ARDX CLDX
Tags MRK CLDX EXEL
From Benzinga
The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK
June 16, 2022
Tickers ACIU ACLX ACOR AQST
Tags News Market News BIIB
From Benzinga
Exelixis-BioInvent Establish Immuno-Oncology Pact
June 16, 2022
Tickers BOVNF EXEL
Tags Health Care News Market News
From Benzinga
4 Supercharged Growth Stocks Billionaires Can't Stop Buying
June 08, 2022
Tickers EXEL SKLZ SQ TSLA
Tags TSLA EXEL SKLZ
From Motley Fool
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on
May 24, 2022
Tickers ADT ALB AVLR BILL
Tags RE Market News Today's Market
From InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
May 19, 2022
Tickers ACRX CYAD DAWN DRTS
Tags ACRX TNYA CYAD
From Benzinga
Can This Cancer Stock Maintain Its Momentum?
May 18, 2022
Tickers EXEL
Tags Market News Recent Press Releases EXEL
From Motley Fool
Buying These 3 Stocks Could Be the Smartest Investing Move You Ever Make
May 17, 2022
Tickers BMY ETSY EXEL IPSEY
Tags Market News Recent Press Releases BMY
From Motley Fool
Exelixis (EXEL) Q1 2022 Earnings Call Transcript
May 11, 2022
Tickers EXEL
Tags EXEL Recent Press Releases Market News
From Motley Fool
Exelixis: Q1 Earnings Insights
May 10, 2022
Tickers EXEL
Tags Market News BZI/Recaps Earnings
From Benzinga
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
May 10, 2022
Tickers AGEN ARWR ATNX AVGR
Tags M&A AVGR FDA
From Benzinga
3 Growth Stocks to Buy With $1,000 Right Now
May 03, 2022
Tickers BMY CURLF EXEL PINS
Tags EXEL BMY Recent Press Releases
From Motley Fool
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
May 03, 2022
Tickers ACAD AQST BIIB BLTE
Tags VCYT Small Cap OCUL
From Benzinga
Ipsen - Exelixis' Cabometyx Scores European Approval As Second-Line Treatment For Thyroid Cancer
May 03, 2022
Tickers EXEL IPSEF IPSEY
Tags Briefs News Market News
From Benzinga
7 Top-Rated Biotech Stocks to Buy for Q2
April 21, 2022
Tickers BCRX BNTX EXEL ITOS
Tags NASDAQ:BNTX,NASDAQ:BCRX,NASDAQ:MRNA,NASDAQ:MRUS,NASDAQ:ITOS,NASDAQ:EXEL,NASDAQ:RGNX,NYSE:PFE Market News RGNX
From InvestorPlace
Nasdaq Bear Market: 3 of the Safest Stocks to Buy on the Dip
April 13, 2022
Tickers AVGO BRK-A BRK-B EXEL
Tags BRK/B ^IXIC Market News
From Motley Fool
3 No-Brainer Stocks to Buy With $1,000 During the Market Sell-Off
April 01, 2022
Tickers AVGO EXEL FB
Tags EXEL Recent Press Releases AVGO
From Motley Fool
2 Stocks Defying the Market Sell-Off Right Now
March 29, 2022
Tickers BMY EXEL
Tags Recent Press Releases BMY EXEL
From Motley Fool
EMA's Scientific Committee Backs Expanded Use Of Exelixis, Ipsen's Cabometyx In Thyroid Cancer
March 25, 2022
Tickers EXEL IPSEF IPSEY
Tags Biotech Benzinga EXEL
From Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
March 15, 2022
Tickers ALT ANAB ANIP ATHX
Tags FDA TCON ALT
From Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
March 15, 2022
Tickers BAYRY BAYZF EXEL IPSEY
Tags Benzinga EXEL Biotech
From Benzinga
3 Stocks That Can Turn $10,000 Into $50,000 by 2025
March 11, 2022
Tickers EXEL FIGS NVAX
Tags EXEL Recent Press Releases FIGS
From Motley Fool
2 Biotech Stocks That Could Make You Richer
March 02, 2022
Tickers BMY EXEL ICPT RHHBY
Tags Market News ICPT BMY
From Motley Fool
3 Surefire Stocks to Buy Hand Over Fist During the Stock Market Sell-Off
February 25, 2022
Tickers EXEL GM MA
Tags GM EXEL Recent Press Releases
From Motley Fool
Exelixis (EXEL) Q4 2021 Earnings Call Transcript
February 18, 2022
Tickers EXEL
Tags EXEL Recent Press Releases Market News
From Motley Fool
Exelixis: Q4 Earnings Insights
February 17, 2022
Tickers EXEL
Tags Market News BZI/Recaps Earnings
From Benzinga
Earnings Scheduled For February 17, 2022
February 17, 2022
Tickers AAWW AEE AEL AL
Tags AL NR GEL
From Benzinga
Earnings Preview For Exelixis
February 16, 2022
Tickers EXEL
Tags Market News BZI/EP Earnings
From Benzinga
Bristol Myers, Exelixis Tout Additional Opdivo/Cabometyx Combo Data From Kidney Cancer Trial
February 15, 2022
Tickers BMY EXEL
Tags renal cell carcinoma Phase 3 Trial Market News
From Benzinga
2 Biotech Stocks That Could Make You Richer
February 02, 2022
Tickers BLUE EXEL TSVT
Tags TSVT Market News EXEL
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap